Safety and efficacy of restarting immune checkpoint inhibitors in non-small cell lung cancer patients following immune-related adverse events: a systematic review and meta-analysis. - Tan K; Wang A; Zheng Y; Wang S; Wang C; Li J; Lu X; Dong H; Zheng J; Cui H (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025)